Skip to main content

Advertisement

Table 4 Variation in promotion and research and development spending by individual company by year

From: Pharmaceutical company spending on research and development and promotion in Canada, 2013-2016: a cohort analysis

Company Promotion spending on drugs in 50 most promoted ($000) Research and development spending ($000)
2013 2014 2015 2016 2013 2014 2015 2015
Abbott EPD 15,779 16,009 8104 0 0 0
Actavis 3034 2753 20 0
Allergan 2328 1751
Amgen 5816 5836 6515 6359 50,370 45,622 42,153 38,600
Astellas 3006 3097 8094 5612 4735 3447 6952 3851
AstraZeneca 20,066 35,416 33,655 41,304 13,781 24,273 41,143 61,468
Bayer 10,857 11,995 11,486 11,898 23,476 31,373 39,719 45,025
BGP Pharma 4809 0
BMS Pharma 20,081 13,132 7588 14,741 53,270 45,001 59,456 81,335
Boehringer Ingelheim 11,570 17,304 14,147 24,961 23,476 18,430 22,742 21,409
GlaxoSmithKline 19,384 30,547 13,328 27,567 88,350 77,648 53,413 43,326
Janssen 5636 12,666 16,839 6356 49,983 61,733 70,646 86,380
Leo 3847 939
Lilly 12,358 8261 7592 6150 53,672 26,620 22,277 36,710
Lundbeck 9956 3322 12,146 8900 888 2596 3126 0
Merck 27,682 13,065 18,441 36,963 19,962 26,505 21,667 32,582
Novartis 3460 7838 5376 12,002 106,013 78,553 51,916 44,701
Novo Nordisk 6536 4159 3517 3580 4563 10,857 7886 4548
Paladin 3113 265
Pfizer 24,429 12,009 12,178 14,162 24,643 14,174 8953 9738
Purdue 9996 3790 6099 2666 13,581 14,683 12,609 16,321
Sanofi-Aventis 3222 2870 3578 19,940 13,847 8450
Servier 7862 14,134 8893 7252 11.745 13,612 8067 7150
Shire 4145 6967 3287 3464 281 350 0 0
Takeda 14,099 13,415 19,582 5460 0 0 0 0
Valeant 3633 3535 7414 8251 0 0 14,231 9712